In the Real World of STD Prevention rubric of the November issue of the journal Sexually Transmitted Diseases, an article appeared that examines the intersection of two emerging issues in the control of sexually transmitted infections, i.e., the increasing use of expedited partner therapy for the management of partners of persons with gonorrhea and chlamydia on the one hand and the growing importance of federally qualified health centers for the provision of STD management on the other
Because EPT has been demonstrated to reduce the transmission of chlamydia and gonorrhea, widespread adoption of this prevention strategy by an increasingly important provider of STD care may have significant impact on STD control in the Unites States.
Here to discuss the paper is Dr. Julie Schillinger who is a Medical Officer in the Division of STD Prevention at the U.S. Centers for Disease Control. She is stationed in New York City where she is the Director of Surveillance, Epidemiology, and Research, in the Bureau of STD Control, NYC Department of Health and Mental Hygiene. She has extensive experience in STD research and was the lead author of a randomized controlled trial that demonstrated the efficacy of EPT for chlamydial infections, published a little more than 10 years ago.
The article is available at no cost at this link.